Assessment of multidrug resistance associated P - glycoprotein and BCL - 2 in chronic lymphocytic leukemia /
Amina Mohamed Talat Elnaggar
Assessment of multidrug resistance associated P - glycoprotein and BCL - 2 in chronic lymphocytic leukemia / تقدير مقاومة العديد من الادوية المصاحبة للجليكوبروتين (ب) وب س ل - 2 فى حالات سرطان الدم الليمفاوى المزمن Amina Mohamed Talat Elnaggar ; Supervised Amira Mokhtar Khorshed , Samah Ali Mostafa , Thoraya Mohamed Abd El hamid - Cairo : Amina Mohamed Talat Elnaggar , 2005 - 159p ; 25cm
Thesis (PH.D.) - Cairo University - National Cancer Institute - Department Of Clinical Pathology
A major problem in the treatment of leukemia and lymphoma is caused by the development of drug resistance to chemotherapeutic agents at diagnosis or after chemotherapy induced by drug - resistance proteins such as P - glycoprotein , which work as a drug efflux pump and has antiapoptotic action
Bcl - 2 Chronic lymphocytic leukemia FCM and ICC Multidrug resistance P.glycoprotein
Assessment of multidrug resistance associated P - glycoprotein and BCL - 2 in chronic lymphocytic leukemia / تقدير مقاومة العديد من الادوية المصاحبة للجليكوبروتين (ب) وب س ل - 2 فى حالات سرطان الدم الليمفاوى المزمن Amina Mohamed Talat Elnaggar ; Supervised Amira Mokhtar Khorshed , Samah Ali Mostafa , Thoraya Mohamed Abd El hamid - Cairo : Amina Mohamed Talat Elnaggar , 2005 - 159p ; 25cm
Thesis (PH.D.) - Cairo University - National Cancer Institute - Department Of Clinical Pathology
A major problem in the treatment of leukemia and lymphoma is caused by the development of drug resistance to chemotherapeutic agents at diagnosis or after chemotherapy induced by drug - resistance proteins such as P - glycoprotein , which work as a drug efflux pump and has antiapoptotic action
Bcl - 2 Chronic lymphocytic leukemia FCM and ICC Multidrug resistance P.glycoprotein